Helix is the leading population genomics company working at the intersection of clinical care, research, and genomics. Its end-to-end platform enables health systems, life sciences companies, and payers to advance genomic research and accelerate the integration of genomic data into clinical care. Powered by one of the world’s largest CLIA / CAP next-generation sequencing labs and its proprietary Exome+® assay, Helix supports all aspects of population genomics including recruitment and engagement, clinically actionable disease screening, return of results, and basic and translational research.
Warburg Pincus is a leading global private equity firm focused on thesis-driven growth investing at scale. With more than $58 billion in assets under management, our active portfolio of more than 190 companies is highly diversified by stage, sector and geography. As an experienced partner to outstanding management teams, we help build durable companies with sustainable value. We have raised 19 private equity funds, which have invested more than $81 billion in over 890 companies in more than 40 countries.